IPOPLUS

₹224.97

▼ -3.14 -1.38%

18 Jun 2026

NSE Listed · Healthcare

Laxmi Dental Limited (LAXMIDENTL)

Volume: 10,185Avg Vol 1W: 4,35,747Avg Vol 1M: 1,73,56652W Range:₹155.88₹509.95
NSE BSE
₹224.97▼ 1.38%
Key Ratios
Updated just now
Market Cap₹1,242 Cr
Current Price₹224.97
Previous Close₹228.11
High / Low (52w)₹509.95 / ₹155.88
Volume10,185
Avg Vol (1W)4,35,747
Avg Vol (1M)1,73,566
Stock P/E76.83
Book Value₹44.28
Dividend Yield0%
ROE13.74%
ROA8.99%
Revenue (TTM)—
Revenue Growth23.53%
Profit Margin10.67%
Total Debt₹11 Cr
Shares Outstanding5 Cr
Face Value₹2
EPS (TTM)₹1.83
P/B4.85
Debt / Equity0.05
50 DMA₹222.05
200 DMA₹200.78
Day change-1.38%
Price Chart
₹224.97▼ 29.14% · 1Y
₹383₹15763.2L
2025-10-21
2026-06-16

20-day avg volume: 1.7L shares

Pros
  • Company is almost debt-free.
  • Revenue grew 24% YoY.
  • Net profit is growing year over year.
Cons
  • Stock trades at a high P/E of 77.
Quarterly Results
MetricMar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023
Revenue₹74 Cr₹66 Cr₹72 Cr₹66 Cr₹61 Cr₹62 Cr₹57 Cr₹60 Cr₹55 Cr₹48 Cr
EBITDA₹11 Cr₹5 Cr₹10 Cr₹10 Cr₹7 Cr₹6 Cr₹6 Cr₹11 Cr₹9 Cr₹1 Cr
Net Profit₹10 Cr₹2 Cr₹9 Cr₹8 Cr₹4 Cr₹5 Cr₹6 Cr₹17 Cr₹8 Cr₹2 Cr
EPS1.830.361.581.520.780.882.123.24247.0176.3
Profit & Loss (Annual)
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Revenue₹242 Cr₹195 Cr₹164 Cr₹138 Cr₹97 Cr₹153 Cr
EBITDA₹30 Cr₹14 Cr₹0 Cr₹-2 Cr₹2 Cr₹0 Cr
Net Profit₹32 Cr₹25 Cr₹-4 Cr₹-18 Cr₹-5 Cr₹-5 Cr
EPS6.054.8-0.77-3.56-156-155
Balance Sheet
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Total Assets₹285 Cr₹135 Cr₹97 Cr₹103 Cr₹106 Cr₹106 Cr
Total Liabilities₹76 Cr₹90 Cr₹77 Cr₹80 Cr₹61 Cr₹57 Cr
Equity₹209 Cr₹45 Cr₹19 Cr₹23 Cr₹44 Cr₹49 Cr
Total Debt₹11 Cr₹15 Cr₹11 Cr₹10 Cr₹12 Cr₹8 Cr
Cash Flow
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Operating₹46 Cr₹9 Cr₹15 Cr₹-2 Cr₹10 Cr₹10 Cr
Investing₹-29 Cr₹-11 Cr₹-9 Cr₹3 Cr₹-9 Cr₹-18 Cr
Financing₹111 Cr₹-3 Cr₹-1 Cr₹-4 Cr₹0 Cr₹6 Cr
Free Cash Flow₹46 Cr₹9 Cr₹15 Cr₹-2 Cr₹10 Cr₹10 Cr
Shareholding
Promoter 41.77% Institutions 19.32% Public 38.91%

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search